News
Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, ...
Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition ...
A phased rollout of Mounjaro is set to begin across the UK next week as GP surgeries issue an urgent warning to patients.
Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy for beginners now. On June 11, Eli Lilly announced a ...
Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...
Reuters on MSN22h
Lilly will offer higher doses of Zepbound on its websiteEli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...
There’s a lot of stigma around Mounjaro and a recent study found that people think weight loss that’s brought on by weight ...
Eli Lilly will add 12.5 mg and 15 mg single-dose vials of its weight loss drug Zepbound to its LillyDirect platform starting July 7, completing the full range of approved doses. All vial doses, ...
Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
Eli Lilly will start selling the two highest doses of its popular weight-loss drug Zepbound directly to customers online in ...
At 12 weeks, weight loss ranged from 2.6% to 11.3%, compared to a gain of 0.2% in the placebo group. Guggenheim analysts were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results